Gelonghui, December 26 | Shanghai Pharmaceutical (601607.SH) fell more than 1% at the beginning of the session, hitting a low of 16.33 yuan. According to a research report recently released by Da Mo, according to Shanghai Pharmaceutical's quarterly results for the third quarter, the company's profit estimates from 2023 to 2030 were lowered by about 4% to 8%, based on low sales in the manufacturing sector, and its H-share target price was lowered from HK$19 to HK$18, maintaining the “increased holdings” rating.
A股异动｜上海医药一度跌超1% 大摩下调盈测及H股目标价
Changes in A-shares | Shanghai Pharmaceutical once fell by more than 1%, and Damo lowered profit estimates and H-share target prices
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.